A federal judge upheld Indiana University’s requirement for vaccination against the coronavirus in a ruling made public Monday, rejecting arguments from students who contended the mandate was unconstitutional.
The split on mandates often follows a red-blue political divide. Colleges that require vaccination are more likely to be located in states that President Biden carried in last year’s election.
IU, with about 90,000 students on several campuses, is one of the most prominent public universities in a Republican-led state to adopt a vaccine mandate. Purdue University, also in Indiana, does not have a mandate.
Eight IU students challenged the university’s policy in a lawsuit filed last month in the U.S. District Court for the Northern District of Indiana, saying the mandate infringed on their bodily autonomy and medical privacy. Several of the plaintiffs had obtained exemptions that the university offered from the mandate on religious grounds, but they nonetheless viewed the policy as an attack on their rights and sought a preliminary injunction to halt the mandate.
U.S. District Judge Damon R. Leichty sided with the university in declining to issue an injunction after hearing oral arguments on July 13.
“Recognizing the students’ significant liberty to refuse unwanted medical treatment, the Fourteenth Amendment permits Indiana University to pursue a reasonable and due process of vaccination in the legitimate interest of public health for its students, faculty, and staff,” Leichty wrote in an opinion dated Sunday. “Today, on this preliminary record, the university has done so for its campus communities. The students haven’t established a likelihood of success on the merits of their Fourteenth Amendment claim or the many requirements that must precede the extraordinary remedy of a preliminary injunction.”
Leichty, a Trump appointee, wrote in the ruling that the lawsuit posed new and urgent questions.
“No case to date has decided the constitutionality of whether a public university, such as Indiana University, may mandate that its students receive a COVID-19 vaccine,” Leichty wrote.
He noted the most widely used coronavirus vaccines are being administered through emergency use authorization, or EUA, and still do not yet have full approval from the Food and Drug Administration. But the pandemic posed a rare public health threat, the judge wrote, citing the covid-19 death toll in America of more than 600,000.
“Not all EUAs are equal,” Leichty wrote, “and the one required for COVID-19 vaccines was more robust than usual.”
James Bopp Jr., attorney for the plaintiffs, said in a statement that they would appeal.
“Continuing our fight against this unconstitutional mandate is necessary to guarantee that IU students receive the fair due process they’re owed by a public university,” Bopp said. “An admitted IU student’s right to attend IU cannot be conditioned on the student waiving their rights to bodily integrity, bodily autonomy, and consent to medical treatment like IU has done here.”
The university applauded the outcome.
“A ruling from the federal court has affirmed Indiana University’s COVID-19 vaccination plan designed for the health and well-being of our students, faculty and staff,” IU said in a statement. “We appreciate the quick and thorough ruling which allows us to focus on a full and safe return. We look forward to welcoming everyone to our campuses for the fall semester.”
IU’s mandate, issued in May, applies to students and employees. So far, an IU spokesman said, about 80 percent of students, faculty and staff have had at least one vaccine shot. Classes resume in August on the main campus in Bloomington and elsewhere.
Coronavirus: What you need to know
End of the public health emergency: The Biden administration ended the public health emergency for the coronavirus pandemic on May 11, just days after WHO said it would no longer classify the coronavirus pandemic as a public health emergency. Here’s what the end of the covid public health emergency means for you.
Tracking covid cases, deaths: Covid-19 was the fourth leading cause of death in the United States last year with covid deaths dropping 47 percent between 2021 and 2022. See the latest covid numbers in the U.S. and across the world.
The latest on coronavirus boosters: The FDA cleared the way for people who are at least 65 or immune-compromised to receive a second updated booster shot for the coronavirus. Here’s who should get the second covid booster and when.
New covid variant: A new coronavirus subvariant, XBB. 1.16, has been designated as a “variant under monitoring” by the World Health Organization. The latest omicron offshoot is particularly prevalent in India. Here’s what you need to know about Arcturus.
Would we shut down again? What will the United States do the next time a deadly virus comes knocking on the door?
For the latest news, sign up for our free newsletter.